Polyclonality of BRAF Mutations in Acquired Melanocytic Nevi

被引:51
作者
Lin, Jingrong [1 ]
Takata, Minoru [1 ]
Murata, Hiroshi [1 ]
Goto, Yasufumi [1 ]
Kido, Kenji [1 ]
Ferrone, Soldano [2 ,3 ]
Saida, Toshiaki [1 ]
机构
[1] Shinshu Univ, Dept Dermatol, Sch Med, Matsumoto, Nagano 3908621, Japan
[2] Univ Pittsburgh, Inst Canc, Dept Surg, Dept Immunol, Pittsburgh, PA USA
[3] Univ Pittsburgh, Dept Pathol, Inst Canc, Pittsburgh, PA USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2009年 / 101卷 / 20期
关键词
HUMAN-MELANOMA CELLS; SIGNALING PATHWAY; HIGH-FREQUENCY; ACTIVATION; SENESCENCE; CANCER;
D O I
10.1093/jnci/djp309
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Melanocytic nevi are thought to be senescent clones of melanocytes that have acquired an oncogenic BRAF mutation. BRAF mutation is considered to be a crucial step in the initiation of melanocyte transformation. However, using immunomagnetic separation or laser-capture microdissection, we examined BRAF mutations in sets of approximately 50 single cells isolated from acquired melanocytic nevi from 13 patients and found a substantial number of nevus cells that contained wild-type BRAF mixed with nevus cells that contained BRAF(V600E). Furthermore, we simultaneously amplified BRAF exon 15 and a neighboring single nucleotide polymorphism (SNP), rs7801086, from nevus cell samples obtained from four patients who were heterozygous for this SNP. Subcloning and sequencing of the polymerase chain reaction products showed that both SNP alleles harbored the BRAF(V600E) mutation, indicating that the same BRAF(V600E) mutation originated from different cells. The polyclonality of BRAF mutations in acquired melanocytic nevi suggests that mutation of BRAF may not be an initial event in melanocyte transformation.
引用
收藏
页码:1423 / 1427
页数:5
相关论文
共 15 条
  • [1] NAMING ACQUIRED MELANOCYTIC NEVI UNNA, MIESCHER, SPITZ, CLARK
    ACKERMAN, AB
    MAGANAGARCIA, M
    [J]. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1990, 12 (02) : 193 - 209
  • [2] Human high molecular weight-melanoma-associated antigen (HMW-MAA): A melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance
    Campoli, MR
    Chang, CC
    Kageshita, T
    Wang, X
    McCarthy, JB
    Ferrone, S
    [J]. CRITICAL REVIEWS IN IMMUNOLOGY, 2004, 24 (04) : 267 - 296
  • [3] Mutations of the BRAF gene in human cancer
    Davies, H
    Bignell, GR
    Cox, C
    Stephens, P
    Edkins, S
    Clegg, S
    Teague, J
    Woffendin, H
    Garnett, MJ
    Bottomley, W
    Davis, N
    Dicks, N
    Ewing, R
    Floyd, Y
    Gray, K
    Hall, S
    Hawes, R
    Hughes, J
    Kosmidou, V
    Menzies, A
    Mould, C
    Parker, A
    Stevens, C
    Watt, S
    Hooper, S
    Wilson, R
    Jayatilake, H
    Gusterson, BA
    Cooper, C
    Shipley, J
    Hargrave, D
    Pritchard-Jones, K
    Maitland, N
    Chenevix-Trench, G
    Riggins, GJ
    Bigner, DD
    Palmieri, G
    Cossu, A
    Flanagan, A
    Nicholson, A
    Ho, JWC
    Leung, SY
    Yuen, ST
    Weber, BL
    Siegler, HF
    Darrow, TL
    Paterson, H
    Marais, R
    Marshall, CJ
    Wooster, R
    [J]. NATURE, 2002, 417 (6892) : 949 - 954
  • [4] Activation of toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors
    Goto, Yasufumi
    Arigami, Takaaki
    Kitago, Minoru
    Nguyen, Sandy L.
    Narita, Norihiko
    Ferrone, Soldano
    Morton, Donald L.
    Irie, Reiko F.
    Hoon, Dave S. B.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2008, 7 (11) : 3642 - 3653
  • [5] Cellular senescence in naevi and immortalisation in melanoma: a role for p16?
    Gray-Schopfer, V. C.
    Cheong, S. C.
    Chong, H.
    Chow, J.
    Moss, T.
    Abdel-Malek, Z. A.
    Marais, R.
    Wynford-Thomas, D.
    Bennett, D. C.
    [J]. BRITISH JOURNAL OF CANCER, 2006, 95 (04) : 496 - 505
  • [6] High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi
    Ichii-Nakato, Nami
    Takata, Minoru
    Takayanagi, Shuko
    Takashima, Shiho
    Lin, Jingrong
    Murata, Hiroshi
    Fujimoto, Akihide
    Hatta, Naohito
    Saida, Toshiaki
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (09) : 2111 - 2118
  • [7] BRAFE600 in benign and malignant human tumours
    Michaloglou, C.
    Vredeveld, L. C. W.
    Mooi, W. J.
    Peeper, D. S.
    [J]. ONCOGENE, 2008, 27 (07) : 877 - 895
  • [8] BRAFE600-associated senescence-like cell cycle arrest of human naevi
    Michaloglou, C
    Vredeveld, LCW
    Soengas, MS
    Denoyelle, C
    Kuilman, T
    van der Horst, CMAM
    Majoor, DM
    Shay, JW
    Mooi, WJ
    Peeper, DS
    [J]. NATURE, 2005, 436 (7051) : 720 - 724
  • [9] MIRANDA M, 1994, BIOCHEM MOL BIOL INT, V32, P913
  • [10] X-inactivation patch size in human female tissue confounds the assessment of tumor clonality
    Novelli, M
    Cossu, A
    Oukrif, D
    Quaglia, A
    Lakhani, S
    Poulsom, R
    Sasieni, P
    Carta, P
    Contini, M
    Pasca, A
    Palmieri, G
    Bodmer, W
    Tanda, F
    Wright, N
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (06) : 3311 - 3314